#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2216585	B	Inhibition of Kv1.3 expressed in mouse L929 cells exposed to depolarizing step pulses from -80 mV to +40 mV by whole cell patch clamp method		22		cell-based format	Scientific Literature
2.	ALA4428507	B	Inhibition of CRT CVIET haplotype mutant in Plasmodium falciparum K1 isolate MRA-159 infected in erythrocytes assessed as chloroquine-coumarin probe accumulation at 10 uM after 10 hrs by Hoechst 33342 staining based flow cytometry (Rvb = 35.57 +/- 3.84%)	Plasmodium falciparum K1	38		cell-based format	Scientific Literature
3.	ALA4428509	F	Potentiation of chloroquine-induced antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 isolate MRA-102 assessed as reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		organism-based format	Scientific Literature
4.	ALA4428510	F	Potentiation of chloroquine-induced antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 isolate MRA-155 assessed as reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		organism-based format	Scientific Literature
5.	ALA4428511	B	Inhibition of CRT SVMNT haplotype mutant in intermediate chloroquine-resistant Plasmodium falciparum 7G8 isolate MRA-154 t assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum 7G8	11		assay format	Scientific Literature
6.	ALA4428512	B	Inhibition of CRT CVIET haplotype mutant in chloroquine-resistant Plasmodium falciparum K1 isolate MRA-159 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum K1	11		assay format	Scientific Literature
7.	ALA4428513	B	Inhibition of CRT K76T mutant in chloroquine-resistant Plasmodium falciparum Dd2 isolate MRA-156 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum Dd2	11		single protein format	Scientific Literature
8.	ALA4428514	B	Inhibition of CRT K76T mutant in chloroquine/artemisinin-resistant Plasmodium falciparum ARS233 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		single protein format	Scientific Literature
9.	ALA4428515	B	Inhibition of CRT K76T mutant in chloroquine/artemisinin-resistant Plasmodium falciparum ARS272 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		single protein format	Scientific Literature
10.	ALA4428516	B	Inhibition of CRT K76T mutant in chloroquine-resistant Plasmodium falciparum NHP4559 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		single protein format	Scientific Literature
11.	ALA4428517	B	Inhibition of CRT K76T mutant in chloroquine/artemisinin-resistant Plasmodium falciparum NHP4773 assessed as reversal of chloroquine resistance by measuring reduction in chloroquine IC50 at 500 nM relative to chloroquine alone	Plasmodium falciparum	11		single protein format	Scientific Literature
12.	ALA4428518	F	Intrinsic antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 isolate MRA-102 assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
13.	ALA4428519	F	Intrinsic antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 isolate MRA-155 assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
14.	ALA4428520	F	Intrinsic antimalarial activity against intermediate chloroquine-resistant Plasmodium falciparum 7G8 isolate MRA-154 harboring CRT SVMNT haplotype mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
15.	ALA4428521	F	Intrinsic antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 isolate MRA-159 harboring CRT CVIET haplotype mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
16.	ALA4428522	F	Intrinsic antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 isolate MRA-156 harboring CRT K76T mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
17.	ALA4428523	F	Intrinsic antimalarial activity against chloroquine/artemisinin-resistant Plasmodium falciparum ARS233 harboring CRT K76T mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
18.	ALA4428524	F	Intrinsic antimalarial activity against chloroquine/artemisinin-resistant Plasmodium falciparum ARS272 harboring CRT K76T mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
19.	ALA4428525	F	Intrinsic antimalarial activity against chloroquine-resistant Plasmodium falciparum NHP4559 harboring CRT K76T mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature
20.	ALA4428526	F	Intrinsic antimalarial activity against chloroquine/artemisinin-resistant Plasmodium falciparum NHP4773 harboring CRT K76T mutant assessed as reduction in parasite viability at 500 nM	Plasmodium falciparum	37		organism-based format	Scientific Literature